Board Certified Neurosurgeon Joins DHR Health Neuroscience Institute  

Community NewsNews
13779

Translate to Spanish or other 102 languages!

Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source: googlemaps
Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source: googlemaps

Mega Doctor News

- Advertisement -

Edinburg, TX – The DHR Health Neuroscience Institute is pleased to welcome Inad B. Atassi, M.D, F.A.C.S., to the team. Utilizing the most advanced surgical techniques to provide comprehensive neurological care to patients, Dr. Atassi specializes in the treatment of brain tumors, spinal cord tumors, stroke and traumatic head & spine injuries.

Dr. Atassi is Board Certified in Neurosurgery and brings more than 35 years of experience in the field to patients of the Rio Grande Valley. He received his Doctor of Medicine at Damascus University in Damascus, Syria. He completed his General Surgery residency at Henry Ford Hospital in Detroit, Michigan and continued his Neurosurgery residency training at the University of Kansas Medical Center in Kansas City, Kansas.

Dr. Atassi has been in private practice, as well as worked in clinics and hospitals around the world providing neurologic care to adult and pediatric patients before bringing his talents to South Texas in 2020.He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, American College of Surgeons, North Carolina Medical Society, Cumberland County Medical Society, and North American Spine Society.

- Advertisement -

To schedule an appointment with Dr. Atassi, please call (956) 362-8500.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Type of early-onset dementia now more detectible
Next article
New Sleep Guidelines Issued for Infants

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.
- Advertisement -